Amit Bar-Or, MD, FRCPC / Ludwig Kappos, MD, FEAN, FAAN - The Rise of B-Cell Therapies in Relapsing MS: Examining the State of the Science, New Therapeutic Options, and Patient-Centered Clinical Decision-Making - a podcast by PVI, PeerView Institute for Medical Education
from 2021-06-16T18:00
Go online to PeerView.com/WEN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in neurology discuss treatment with B-cell therapies in patients with multiple sclerosis. Upon completion of this accredited CE activity, participants should be better able to: Describe the role of B cells in the pathogenesis of relapsing multiple sclerosis (MS), Recognize the similarities and differences between anti-CD20 monoclonal antibodies available for the treatment of relapsing forms of MS, Analyze available evidence on investigational B-cell–targeting therapies, Employ a patient-centered approach to treatment selection for patients with MS based on their disease activity, treatment preferences and goals, and therapeutic options.
Further episodes of PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Further podcasts by PVI, PeerView Institute for Medical Education